Vitality Portfolio is a registered fund series of MORGAN STANLEY INSTITUTIONAL FUND INC (series S000074797). Net assets $2.1M as of 2026-03-31.
Showing 15 of 33 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Argenx SE | — | $172K | 802.60% |
| Eli Lilly & Co | — | $166K | 778.60% |
| Ascendis Pharma A/S | — | $117K | 547.71% |
| Nektar Therapeutics | — | $102K | 475.14% |
| Thermo Fisher Scientific Inc | — | $91K | 427.58% |
| Align Technology Inc | — | $89K | 417.72% |
| Enliven Therapeutics Inc | — | $83K | 389.77% |
| 10X Genomics Inc | — | $81K | 377.40% |
| Newamsterdam Pharma Co NV | — | $76K | 356.75% |
| Structure Therapeutics Inc | — | $72K | 335.66% |
| Ceribell Inc | — | $72K | 335.62% |
| Doximity Inc | — | $63K | 292.92% |
| Intuitive Surgical Inc | — | $61K | 284.59% |
| Guardant Health Inc | — | $58K | 272.60% |
| Alnylam Pharmaceuticals Inc | — | $58K | 270.80% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $2.1M |
| 2025-12-31 | $2.3M |
| 2025-09-30 | $2.0M |
| 2025-06-30 | $1.9M |
| 2025-03-31 | $1.9M |
| 2024-12-31 | $2.0M |
| 2024-09-30 | $2.3M |
| 2024-06-30 | $2.1M |